Actionable news
All posts from Actionable news
Actionable news in KITE: KITE PHARMA Inc,

Kite Pharma Expands Leadership Team, Appoints Paul L. Jenkinson as Chief Financial Officer

SANTA MONICA, Calif., May 16, 2016 (BUSINESS WIRE) -- Kite Pharma, Inc. KITE, +3.34% today announced the appointment of Paul L. Jenkinson as Chief Financial Officer, reporting to Arie Belldegrun, M.D., FACS, Kite’s Chairman, President, and Chief Executive Officer.

Mr. Jenkinson succeeds Cynthia M. Butitta, who continues in her role as Kite’s Chief Operating Officer. Mr. Jenkinson and Ms. Butitta are working closely on the transition and other ongoing business activities.

“Paul brings extensive experience in international financial management and operations to Kite as we prepare for the potential launch of our lead candidate KTE-C19 next year,” said Dr. Belldegrun. “As Kite continues to grow, our evolving leadership structure reflects the expanding focus and specialized needs of our organization. Paul’s expertise in the development, launch, and commercialization of products in multiple markets, including in the U.S., Europe, Asia, and other regions, directly supports our goal of delivering engineered cell therapies to cancer patients in need. We’re thrilled to have him join our team.”

Mr. Jenkinson joins Kite Pharma after nearly a decade at Allergan, where he served most recently as Vice President, Global Commercial and Corporate Finance. In this role, he was responsible for the corporation’s financial planning and analysis activities, working with commercial operations, manufacturing operations, research and development, and general and administration...